ACADIA Pharmaceuticals Inc (ACAD)

NASDAQ
16.75
-0.24(-1.41%)
After Hours
16.89
+0.14(+0.84%)
- Real-time Data
  • Volume:
    1,331,016
  • Day's Range:
    16.40 - 16.98
  • 52 wk Range:
    12.24 - 28.06

ACAD Overview

Prev. Close
16.99
Day's Range
16.4-16.98
Revenue
512.4M
Open
16.84
52 wk Range
12.24-28.06
EPS
-1.27
Volume
1,331,016
Market Cap
2.71B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,712,723
P/E Ratio
-12.39
Beta
0.707
1-Year Change
-1.12%
Shares Outstanding
161,843,185
Next Earnings Date
Nov 07, 2022
What is your sentiment on ACADIA?
or
Market is currently closed. Voting is open during market hours.

ACADIA Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

ACADIA Pharmaceuticals Inc Analysis

ACADIA Pharmaceuticals Inc Company Profile

ACADIA Pharmaceuticals Inc Company Profile

Employees
514

Acadia Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops and commercializes novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The Company’s pipeline product candidates in CNS areas includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. The Company has initiated a Phase II study evaluating ACP-044 for the treatment of postoperative pain following bunionectomy surgery. The Company also initiated an additional Phase II study evaluating ACP-044 for the treatment of pain associated with osteoarthritis. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).

Read More

Analyst Price Target

Average23.38 (+39.55% Upside)
High37
Low10
Price16.75
No. of Analysts16
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellSellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellSellStrong Sell
SummaryStrong BuyStrong BuyStrong SellSellStrong Sell
  • Mashallaha
    0
    • what is going on
      1
      • Thuyii78857ujuuoukho0ojmBnmnmnBjjkjkBnjkh
        1
        • eh il wait til we trading above bollinger band to short, much safer
          3
          • woops wrong board
            0
        • slow ride to the moon but worth the wait
          0
          • going to the moon
            0
            • get back to 50 please
              1
              • 4197 close imo
                0
                • A italian journalist predict a new clinical trail for the sustrate. This will take time i suppose.
                  0
                  • Somebody knows something.
                    0